|  | Number | Percentage (%) |
---|---|---|---|
Gender | Male | 390 | 73 |
Female | 142 | 27 | |
Age | Median | 50 | Â |
Range | 11–80 |  | |
Pathology | WHO II-III | 532 | 100 |
Stage | I | 39 | 7 |
II | 179 | 34 | |
III | 179 | 34 | |
IVA | 55 | 10 | |
IVB | 80 | 15 | |
T | T1 | 176 | 33 |
T2 | 173 | 33 | |
T3 | 124 | 23 | |
T4 | 59 | 11 | |
N | N0 | 82 | 15 |
N1 | 241 | 45 | |
N2 | 129 | 24 | |
N3 | 80 | 15 | |
Elective IB Irradiation | Yes | 232 | 44 |
No | 300 | 56 | |
Radiation Boost | Primary tumor | 32 | 6 |
Nodal disease | 43 | 8 | |
Chemotherapy | Yes | 451 | 85 |
No | 81 | 15 |